SlideShare a Scribd company logo
Vampirism in the Intensive Care Unit:
A routine practice?
A.M. Ayuso-Alvarez1
, J.A. García Erce2
, S. Gómez-Ramírez3
, A. Sarria4
, M.
Muñoz3
, M. Quintana Díaz1,5
1
Intensive Medicine Service, University Hospital La Paz, Madrid; 2
Blood and Tissue
Bank of Navarra, Pamplona; 3
Perioperative Transfusion Medicine, University of
Málaga, Málaga; 4
National Health School, University of Alcalá (REDISSEC), Alcalá de
Henares; 5
Department of Medicine, Autonomous University, Madrid (Spain).
NO INTEREST CONFLICT
Asesor externo
- AMGEN Oncología 2010/2012
- Roche Anemia 2009
- Ditassa-Ferrer 2004
Charlas, estudios investigación y ayudas a congresos
-Vifor-Uriach/Ferralinze/AMGEN
-Janssen-Cilag/Braun/Celgene/Alexion
-Astra-Tech de Aztra Zeneca/Well-Health?/GSK
-Sanofi Aventis/Esteve/Novartis/Octapharma
-Cobe-Caridian/Roche Oncología/AMGEN Oncologia
Miembro del CAT 2002-2005
Miembro del Documento de Sevilla “Alternativas a la Transfusión”
Miembro del Documento Latino Americano de la Anemia
Miembro de GIEMSA/ Secretario AWGE/Socio SETS/AEHH/NATA
Editor Asociado Revista ANEMIA www.revistaanemia.org
Miembro Comité Científico NATA y TATM
Representante de la SEHH en la ONT
Colaborador del Choosing Wisely en Anestesiología
Vampirism in the Intensive Care Unit:
A routine practice?
Vampirism in the Intensive Care Unit:
A routine practice?
Anaemia, blood loss & transfusion
Prof Muñoz
Vampirism in the Intensive Care Unit:
A routine practice?
NEJM 1986
NEJM 1986
Vampirism in the Intensive Care Unit:
A routine practice?
JAMA 2002; 288:1499-1507
Vampirism in the Intensive Care Unit:
A routine practice?
Vampirism in the Intensive Care Unit:
A routine practice?
http://www.choosingwisely.org/doctor-patient-lists/
Five Recommendations from the Italian Federation of Associations of Hospital
Internal Medicine (FADOI) - 1st List (2014)
http://www.choosingwiselyitaly.org/PDF/ENGracc/Scheda%20FADOI%20(1)%20english.pdf
4. Don’t repeat chemistry testing in the face of clinical and laboratory stability
2012
Vampirism in the Intensive Care Unit:
A routine practice?
2014
Vampirism in the Intensive Care Unit:
A routine practice?
Objectives
Vampirism in the Intensive Care Unit:
A routine practice?
To evaluate the prevalence and factors
associated with of Hospital Acquired Anaemia
in patients admitted to Intensive Care Units
(ICU).
Methods.
Prospective, cross-sectional observational study performed at 5
Spanish hospitals during a 4-month period.
•Data were collected in successive week-days for 7 weeks.
•All patients with ICU <28 days and >24 hours on the day of assessment were
included.
•Variables:
– Clinical and demographic data,
– Phlebotomies (“drawn”) (number and volume),
– Hb change from admission to discharge (DHb), and
– Red blood cell transfusion (RBCT) requirements were collected.
•Data are mean and SD or 95%CI, or number (percentage).
•Student’s t test, Pearson’s χ2
test and lineal regression were performed.
Vampirism in the Intensive Care Unit:
A routine practice?
Results.
Overall, 561 patients (66% male) were included.
Mean age was 58 years;
Mean SOFA at admission 5.7± 0.1
APACHE II score at 24 hours 18.3 ± 0.3.
Mean length of ICU stay was 21 days (95%CI: 19-22 days);
ICU mortality rate 12%.
Most frequent reasons for ICU admission were: neurologic (24%),
respiratory (12%), infectious (12%), or cardiovascular diseases
(10%).
Vampirism in the Intensive Care Unit:
A routine practice?
Results.
No anemia Mild
anemia
Moderate
anemia
Severe
anaemia
All
patients
p
Patients, n 196 213 118 34 561 ---
Admission Hb (g/dL) 14.2 11.2 9.3 6.9 11.5 <0.001
Phlebotomy (mL/day) 31 33 30 32 31 0.468
Surgery, n (%) 66 (34) 88 (41) 47 (40) 9 (27) 244 (38) 0.212
Transfusion, n (%) 42 (21) 85 (40) 69 (58) 30 (88) 260 (40) <0.001
RBCT (units/patient) 1.6 1.6 3.0 5.2 2.1 <0.001
ICU stay (days) 21 21 20 22 21 0.916
Discharge Hb (g/dL) 10.5 9.3 8.1 9.0 9.4 <0.001
D Hb (g/dL) -3.0 -1.5 0.1 2.1 -1.5 <0.001
Vampirism in the Intensive Care Unit:
A routine practice?
Results: Anaemia at Admission
p<0.001
Vampirism in the Intensive Care Unit:
A routine practice?
Results: Anaemia evolution
Vampirism in the Intensive Care Unit:
A routine practice?
Results: Relationship Hb discharge and stay at ICU
p<0.001
Vampirism in the Intensive Care Unit:
A routine practice?
Results.
Total extracted vol
Admission-Discharge
Hb Difference
Hb ICU discharge
RCC Transfused (n)
Vampirism in the Intensive Care Unit:
A routine practice?
PEARSON´S BILATERAL CORRELATION
Results.
Adjusting for Hb at admission, a linear relationship between the extracted
volume / day and the Hb at the discharge (R2 = 0.25, p <0.001) was observed
and on the day of the cut (R2 = 0.43, p <0.001).
Discharged Hb
level
Admission-Discharge Hb
difference
R p R p
ICU admission Hb 0,33 <0,001 -0,67 <0,001
Total extracted mL -0,01 0,007 -0,01 0,007
RCC Transfused (n) -0,022 0,160 -0,022 0,160
With no significant relationship to the number of transfused concentrates.
Vampirism in the Intensive Care Unit:
A routine practice?
PEARSON´S MULTILATERAL CORRELATION
Conclusions.
A significant number of phlebotomies are performed among ICU
patients, which associated with the development/maintenance of
"acquired anemia."
Although 40% require RBCT, it seems to be effective at controlling
Hb level only in those with severe anemia at ICU admission.
Vampirism in the Intensive Care Unit:
A routine practice?
Frietz 2014
Vampirism in the Intensive Care Unit:
A routine practice?
EPIGRAPH
“All great work is the fruit of patience
and perseverance, combined with
tenacious concentration on a subject
over a period of months or years”
Dr Santiago Ramón y Cajal
Navarra-Aragón
Medicine´s Nobel Prize
Please, DONATe and tranfuse WISELY!

More Related Content

What's hot

Pvc respuesta liquidos chest
Pvc respuesta liquidos  chestPvc respuesta liquidos  chest
Pvc respuesta liquidos chest
Juan Gpe. Cruz Valdez
 
Abdelaal E 201304
Abdelaal E 201304Abdelaal E 201304
Shroff A - AIMRADIAL 2013 - Cost effectiveness
Shroff A - AIMRADIAL 2013 - Cost effectivenessShroff A - AIMRADIAL 2013 - Cost effectiveness
Hot Topics in ICM - PINCER Course 25th sept 2015
Hot Topics in ICM - PINCER Course 25th sept 2015Hot Topics in ICM - PINCER Course 25th sept 2015
Hot Topics in ICM - PINCER Course 25th sept 2015
Steve Mathieu
 
Drug modification in crrt
Drug modification in crrt Drug modification in crrt
Drug modification in crrt
krishnaswamy sampathkumar
 
The Citrate Story by David Gattas
The Citrate Story by David GattasThe Citrate Story by David Gattas
The Citrate Story by David Gattas
SMACC Conference
 
Agostoni P 201305
Agostoni P 201305Agostoni P 201305
COMPARISION OF SERUM LACTATE AND BASE DEFICIT AS INDICATORS OF ADEQUATE FLUI...
COMPARISION OF SERUM LACTATE AND BASE DEFICIT AS  INDICATORS OF ADEQUATE FLUI...COMPARISION OF SERUM LACTATE AND BASE DEFICIT AS  INDICATORS OF ADEQUATE FLUI...
COMPARISION OF SERUM LACTATE AND BASE DEFICIT AS INDICATORS OF ADEQUATE FLUI...
Srihari Cattamanchi
 
Dose of hd
Dose of hdDose of hd
Dose of hd
Mostafa Salam
 
Yin, l., . (2013). the surgical treatment for portal hypertension
Yin, l., . (2013). the surgical treatment for portal hypertensionYin, l., . (2013). the surgical treatment for portal hypertension
Yin, l., . (2013). the surgical treatment for portal hypertension
Edgar Geovanny Cardenas Figueroa
 
7. (r)evolution in liver failure in critically ill #uzb40 icu (wilmer)
7. (r)evolution in liver failure in critically ill #uzb40 icu (wilmer)7. (r)evolution in liver failure in critically ill #uzb40 icu (wilmer)
7. (r)evolution in liver failure in critically ill #uzb40 icu (wilmer)
International Fluid Academy
 
Crrt dr osama elshahat 2017
Crrt dr osama elshahat  2017Crrt dr osama elshahat  2017
Crrt dr osama elshahat 2017
FarragBahbah
 
Continuous Renal Replacement Therapy
Continuous Renal Replacement TherapyContinuous Renal Replacement Therapy
Continuous Renal Replacement Therapy
Shairil Rahayu
 
Adequacy of Hemodialysis
Adequacy of HemodialysisAdequacy of Hemodialysis
Adequacy of Hemodialysis
MNDU net
 
Vai trò của dung dịch Albumin trong nhiễm khuẩn huyết và sốc nhiễm khuẩn
Vai trò của dung dịch Albumin trong nhiễm khuẩn huyết và sốc nhiễm khuẩnVai trò của dung dịch Albumin trong nhiễm khuẩn huyết và sốc nhiễm khuẩn
Vai trò của dung dịch Albumin trong nhiễm khuẩn huyết và sốc nhiễm khuẩn
Hinh Nguyễn Văn
 
Value Analysis Committee Presentation - PleuraFlow® ACT® System
Value Analysis Committee Presentation - PleuraFlow® ACT® SystemValue Analysis Committee Presentation - PleuraFlow® ACT® System
Value Analysis Committee Presentation - PleuraFlow® ACT® System
Paul Molloy
 
Dr osama elshahat crrt
Dr osama elshahat crrtDr osama elshahat crrt
Dr osama elshahat crrt
FarragBahbah
 
The Emerging Role of BIomarkers and Bio-Impedance
The Emerging Role of BIomarkers and Bio-ImpedanceThe Emerging Role of BIomarkers and Bio-Impedance
The Emerging Role of BIomarkers and Bio-Impedance
drucsamal
 
Frederic Michard - Perioperative Fluid Management - IFAD 2012
Frederic Michard - Perioperative Fluid Management - IFAD 2012Frederic Michard - Perioperative Fluid Management - IFAD 2012
Frederic Michard - Perioperative Fluid Management - IFAD 2012
International Fluid Academy
 
1 prismaflex crrt intro - seg 1 (2007)
1   prismaflex crrt intro - seg 1 (2007)1   prismaflex crrt intro - seg 1 (2007)
1 prismaflex crrt intro - seg 1 (2007)
Steven Marshall
 

What's hot (20)

Pvc respuesta liquidos chest
Pvc respuesta liquidos  chestPvc respuesta liquidos  chest
Pvc respuesta liquidos chest
 
Abdelaal E 201304
Abdelaal E 201304Abdelaal E 201304
Abdelaal E 201304
 
Shroff A - AIMRADIAL 2013 - Cost effectiveness
Shroff A - AIMRADIAL 2013 - Cost effectivenessShroff A - AIMRADIAL 2013 - Cost effectiveness
Shroff A - AIMRADIAL 2013 - Cost effectiveness
 
Hot Topics in ICM - PINCER Course 25th sept 2015
Hot Topics in ICM - PINCER Course 25th sept 2015Hot Topics in ICM - PINCER Course 25th sept 2015
Hot Topics in ICM - PINCER Course 25th sept 2015
 
Drug modification in crrt
Drug modification in crrt Drug modification in crrt
Drug modification in crrt
 
The Citrate Story by David Gattas
The Citrate Story by David GattasThe Citrate Story by David Gattas
The Citrate Story by David Gattas
 
Agostoni P 201305
Agostoni P 201305Agostoni P 201305
Agostoni P 201305
 
COMPARISION OF SERUM LACTATE AND BASE DEFICIT AS INDICATORS OF ADEQUATE FLUI...
COMPARISION OF SERUM LACTATE AND BASE DEFICIT AS  INDICATORS OF ADEQUATE FLUI...COMPARISION OF SERUM LACTATE AND BASE DEFICIT AS  INDICATORS OF ADEQUATE FLUI...
COMPARISION OF SERUM LACTATE AND BASE DEFICIT AS INDICATORS OF ADEQUATE FLUI...
 
Dose of hd
Dose of hdDose of hd
Dose of hd
 
Yin, l., . (2013). the surgical treatment for portal hypertension
Yin, l., . (2013). the surgical treatment for portal hypertensionYin, l., . (2013). the surgical treatment for portal hypertension
Yin, l., . (2013). the surgical treatment for portal hypertension
 
7. (r)evolution in liver failure in critically ill #uzb40 icu (wilmer)
7. (r)evolution in liver failure in critically ill #uzb40 icu (wilmer)7. (r)evolution in liver failure in critically ill #uzb40 icu (wilmer)
7. (r)evolution in liver failure in critically ill #uzb40 icu (wilmer)
 
Crrt dr osama elshahat 2017
Crrt dr osama elshahat  2017Crrt dr osama elshahat  2017
Crrt dr osama elshahat 2017
 
Continuous Renal Replacement Therapy
Continuous Renal Replacement TherapyContinuous Renal Replacement Therapy
Continuous Renal Replacement Therapy
 
Adequacy of Hemodialysis
Adequacy of HemodialysisAdequacy of Hemodialysis
Adequacy of Hemodialysis
 
Vai trò của dung dịch Albumin trong nhiễm khuẩn huyết và sốc nhiễm khuẩn
Vai trò của dung dịch Albumin trong nhiễm khuẩn huyết và sốc nhiễm khuẩnVai trò của dung dịch Albumin trong nhiễm khuẩn huyết và sốc nhiễm khuẩn
Vai trò của dung dịch Albumin trong nhiễm khuẩn huyết và sốc nhiễm khuẩn
 
Value Analysis Committee Presentation - PleuraFlow® ACT® System
Value Analysis Committee Presentation - PleuraFlow® ACT® SystemValue Analysis Committee Presentation - PleuraFlow® ACT® System
Value Analysis Committee Presentation - PleuraFlow® ACT® System
 
Dr osama elshahat crrt
Dr osama elshahat crrtDr osama elshahat crrt
Dr osama elshahat crrt
 
The Emerging Role of BIomarkers and Bio-Impedance
The Emerging Role of BIomarkers and Bio-ImpedanceThe Emerging Role of BIomarkers and Bio-Impedance
The Emerging Role of BIomarkers and Bio-Impedance
 
Frederic Michard - Perioperative Fluid Management - IFAD 2012
Frederic Michard - Perioperative Fluid Management - IFAD 2012Frederic Michard - Perioperative Fluid Management - IFAD 2012
Frederic Michard - Perioperative Fluid Management - IFAD 2012
 
1 prismaflex crrt intro - seg 1 (2007)
1   prismaflex crrt intro - seg 1 (2007)1   prismaflex crrt intro - seg 1 (2007)
1 prismaflex crrt intro - seg 1 (2007)
 

Similar to VAMPIRISM IN ICU. Anexus. Firenze, Italia. Aprin 2017

Comparison Between Antiviral Combination Therapies Against Hepatitis C Virus ...
Comparison Between Antiviral Combination Therapies Against Hepatitis C Virus ...Comparison Between Antiviral Combination Therapies Against Hepatitis C Virus ...
Comparison Between Antiviral Combination Therapies Against Hepatitis C Virus ...
Mohammed Fathy Zaky
 
Evolution transfusion in a general hospital. Dr García Erce. NATA 2016
Evolution transfusion in a general hospital. Dr García Erce. NATA 2016Evolution transfusion in a general hospital. Dr García Erce. NATA 2016
Evolution transfusion in a general hospital. Dr García Erce. NATA 2016
José Antonio García Erce
 
Journal Club Group fffffffffffffffffffffff1.pptx
Journal Club Group fffffffffffffffffffffff1.pptxJournal Club Group fffffffffffffffffffffff1.pptx
Journal Club Group fffffffffffffffffffffff1.pptx
MyThaoAiDoan
 
Hydroxyethyl starch or saline for
Hydroxyethyl starch or saline forHydroxyethyl starch or saline for
Hydroxyethyl starch or saline for
Vishal Ramteke
 
Louvet et al-2007-hepatology
Louvet et al-2007-hepatologyLouvet et al-2007-hepatology
Louvet et al-2007-hepatology
Virginia Mason Internal Medicine Residency
 
Early Goal-Directed Therapy in Septic Shock
Early Goal-Directed Therapy in Septic ShockEarly Goal-Directed Therapy in Septic Shock
Early Goal-Directed Therapy in Septic Shock
shivabirdi
 
Patient Blood Management
Patient Blood ManagementPatient Blood Management
Patient Blood Management
Mathurange Krishnapillai
 
powerpoint-presentation-Multi-verse tecto.pdf
powerpoint-presentation-Multi-verse tecto.pdfpowerpoint-presentation-Multi-verse tecto.pdf
powerpoint-presentation-Multi-verse tecto.pdf
ssuser9828ab
 
accurate monitoring of intravascular fluid volume
accurate monitoring of intravascular fluid volumeaccurate monitoring of intravascular fluid volume
accurate monitoring of intravascular fluid volume
Philip Binkley MD, MPH
 
Hemorrhage
HemorrhageHemorrhage
Hemorrhage
MedicinaIngles
 
Paraquat Poisoning Treatment iNDIA
 Paraquat Poisoning Treatment iNDIA Paraquat Poisoning Treatment iNDIA
Paraquat Poisoning Treatment iNDIA
JanfronBiomedical
 
Successful Treatment of Paraquat Poisoning
Successful Treatment of Paraquat PoisoningSuccessful Treatment of Paraquat Poisoning
Successful Treatment of Paraquat Poisoning
JanfronBiomedical
 
Blood Purification for Paraquat Poisoning
Blood Purification for Paraquat PoisoningBlood Purification for Paraquat Poisoning
Blood Purification for Paraquat Poisoning
JanfronBiomedical
 
Acute Poisoning Treatment
Acute Poisoning TreatmentAcute Poisoning Treatment
Acute Poisoning Treatment
JanfronBiomedical
 
Surveillance of antimicrobial resistance, antimicrobial use and health-care i...
Surveillance of antimicrobial resistance, antimicrobial use and health-care i...Surveillance of antimicrobial resistance, antimicrobial use and health-care i...
Surveillance of antimicrobial resistance, antimicrobial use and health-care i...
THL
 
Reduce the hospitalization
Reduce the hospitalizationReduce the hospitalization
Reduce the hospitalization
Anna Wu
 
appendix-4---presentation-single-unit-transfusion.pdf
appendix-4---presentation-single-unit-transfusion.pdfappendix-4---presentation-single-unit-transfusion.pdf
appendix-4---presentation-single-unit-transfusion.pdf
htpplqzyafxxsptfln
 
Variceal Bleeding
Variceal Bleeding Variceal Bleeding
Variceal Bleeding
salaheldin abusin
 
Acute kidney Injury in Intensive Care
Acute kidney Injury in Intensive CareAcute kidney Injury in Intensive Care
Acute kidney Injury in Intensive Care
oxicm
 
dr Franciscus Ginting - Sepsis PIN PAPDI Surabaya WS-051019.pdf
dr Franciscus Ginting - Sepsis PIN PAPDI  Surabaya WS-051019.pdfdr Franciscus Ginting - Sepsis PIN PAPDI  Surabaya WS-051019.pdf
dr Franciscus Ginting - Sepsis PIN PAPDI Surabaya WS-051019.pdf
corinafiqliyin
 

Similar to VAMPIRISM IN ICU. Anexus. Firenze, Italia. Aprin 2017 (20)

Comparison Between Antiviral Combination Therapies Against Hepatitis C Virus ...
Comparison Between Antiviral Combination Therapies Against Hepatitis C Virus ...Comparison Between Antiviral Combination Therapies Against Hepatitis C Virus ...
Comparison Between Antiviral Combination Therapies Against Hepatitis C Virus ...
 
Evolution transfusion in a general hospital. Dr García Erce. NATA 2016
Evolution transfusion in a general hospital. Dr García Erce. NATA 2016Evolution transfusion in a general hospital. Dr García Erce. NATA 2016
Evolution transfusion in a general hospital. Dr García Erce. NATA 2016
 
Journal Club Group fffffffffffffffffffffff1.pptx
Journal Club Group fffffffffffffffffffffff1.pptxJournal Club Group fffffffffffffffffffffff1.pptx
Journal Club Group fffffffffffffffffffffff1.pptx
 
Hydroxyethyl starch or saline for
Hydroxyethyl starch or saline forHydroxyethyl starch or saline for
Hydroxyethyl starch or saline for
 
Louvet et al-2007-hepatology
Louvet et al-2007-hepatologyLouvet et al-2007-hepatology
Louvet et al-2007-hepatology
 
Early Goal-Directed Therapy in Septic Shock
Early Goal-Directed Therapy in Septic ShockEarly Goal-Directed Therapy in Septic Shock
Early Goal-Directed Therapy in Septic Shock
 
Patient Blood Management
Patient Blood ManagementPatient Blood Management
Patient Blood Management
 
powerpoint-presentation-Multi-verse tecto.pdf
powerpoint-presentation-Multi-verse tecto.pdfpowerpoint-presentation-Multi-verse tecto.pdf
powerpoint-presentation-Multi-verse tecto.pdf
 
accurate monitoring of intravascular fluid volume
accurate monitoring of intravascular fluid volumeaccurate monitoring of intravascular fluid volume
accurate monitoring of intravascular fluid volume
 
Hemorrhage
HemorrhageHemorrhage
Hemorrhage
 
Paraquat Poisoning Treatment iNDIA
 Paraquat Poisoning Treatment iNDIA Paraquat Poisoning Treatment iNDIA
Paraquat Poisoning Treatment iNDIA
 
Successful Treatment of Paraquat Poisoning
Successful Treatment of Paraquat PoisoningSuccessful Treatment of Paraquat Poisoning
Successful Treatment of Paraquat Poisoning
 
Blood Purification for Paraquat Poisoning
Blood Purification for Paraquat PoisoningBlood Purification for Paraquat Poisoning
Blood Purification for Paraquat Poisoning
 
Acute Poisoning Treatment
Acute Poisoning TreatmentAcute Poisoning Treatment
Acute Poisoning Treatment
 
Surveillance of antimicrobial resistance, antimicrobial use and health-care i...
Surveillance of antimicrobial resistance, antimicrobial use and health-care i...Surveillance of antimicrobial resistance, antimicrobial use and health-care i...
Surveillance of antimicrobial resistance, antimicrobial use and health-care i...
 
Reduce the hospitalization
Reduce the hospitalizationReduce the hospitalization
Reduce the hospitalization
 
appendix-4---presentation-single-unit-transfusion.pdf
appendix-4---presentation-single-unit-transfusion.pdfappendix-4---presentation-single-unit-transfusion.pdf
appendix-4---presentation-single-unit-transfusion.pdf
 
Variceal Bleeding
Variceal Bleeding Variceal Bleeding
Variceal Bleeding
 
Acute kidney Injury in Intensive Care
Acute kidney Injury in Intensive CareAcute kidney Injury in Intensive Care
Acute kidney Injury in Intensive Care
 
dr Franciscus Ginting - Sepsis PIN PAPDI Surabaya WS-051019.pdf
dr Franciscus Ginting - Sepsis PIN PAPDI  Surabaya WS-051019.pdfdr Franciscus Ginting - Sepsis PIN PAPDI  Surabaya WS-051019.pdf
dr Franciscus Ginting - Sepsis PIN PAPDI Surabaya WS-051019.pdf
 

More from José Antonio García Erce

RICA PBM 2023.pptx
RICA PBM 2023.pptxRICA PBM 2023.pptx
RICA PBM 2023.pptx
José Antonio García Erce
 
Hemoterapia Basada en Sentido Común. CEX Jaca 2023.pptx
Hemoterapia Basada en Sentido Común. CEX Jaca 2023.pptxHemoterapia Basada en Sentido Común. CEX Jaca 2023.pptx
Hemoterapia Basada en Sentido Común. CEX Jaca 2023.pptx
José Antonio García Erce
 
INTRODUCCIÓN AL PBM CEX 2023.pptx
INTRODUCCIÓN AL  PBM CEX 2023.pptxINTRODUCCIÓN AL  PBM CEX 2023.pptx
INTRODUCCIÓN AL PBM CEX 2023.pptx
José Antonio García Erce
 
Prodiggest-anemia-y-ferropenia
Prodiggest-anemia-y-ferropeniaProdiggest-anemia-y-ferropenia
Prodiggest-anemia-y-ferropenia
José Antonio García Erce
 
Examen. Curso 2018
Examen. Curso 2018Examen. Curso 2018
Examen. Curso 2018
José Antonio García Erce
 
Manejo de la anemia y déficit de hierro en paciente urológico. Dr Oliva
Manejo de la anemia y déficit de hierro en paciente urológico. Dr OlivaManejo de la anemia y déficit de hierro en paciente urológico. Dr Oliva
Manejo de la anemia y déficit de hierro en paciente urológico. Dr Oliva
José Antonio García Erce
 
Enfermedades poco frecuentes que predisponen a la trombosis
Enfermedades poco frecuentes que predisponen a la trombosis Enfermedades poco frecuentes que predisponen a la trombosis
Enfermedades poco frecuentes que predisponen a la trombosis
José Antonio García Erce
 
Casos Clínicos. Dr Jericó. Jaca 2018
Casos Clínicos. Dr Jericó. Jaca 2018Casos Clínicos. Dr Jericó. Jaca 2018
Casos Clínicos. Dr Jericó. Jaca 2018
José Antonio García Erce
 
Patient Blood Management. Prof A Herrera
Patient Blood Management. Prof A Herrera Patient Blood Management. Prof A Herrera
Patient Blood Management. Prof A Herrera
José Antonio García Erce
 
Actualización en Hemorragia Masiva. Jaca 2018
Actualización en Hemorragia Masiva. Jaca 2018Actualización en Hemorragia Masiva. Jaca 2018
Actualización en Hemorragia Masiva. Jaca 2018
José Antonio García Erce
 
Primer pilar del pbm ( jaca18) Dra Bisbe
Primer pilar del pbm ( jaca18) Dra BisbePrimer pilar del pbm ( jaca18) Dra Bisbe
Primer pilar del pbm ( jaca18) Dra Bisbe
José Antonio García Erce
 
Manejo de anemia y ferropenia (prodiggest). Jaca 2018
Manejo de anemia y ferropenia (prodiggest). Jaca 2018Manejo de anemia y ferropenia (prodiggest). Jaca 2018
Manejo de anemia y ferropenia (prodiggest). Jaca 2018
José Antonio García Erce
 
“Nuevas Pruebas”: Test de Generación de Trombina, Técnicas viscoelásticas, t...
“Nuevas Pruebas”: Test de Generación de Trombina,  Técnicas viscoelásticas, t...“Nuevas Pruebas”: Test de Generación de Trombina,  Técnicas viscoelásticas, t...
“Nuevas Pruebas”: Test de Generación de Trombina, Técnicas viscoelásticas, t...
José Antonio García Erce
 
Antibibrinoliticos ddavp-jaca
Antibibrinoliticos ddavp-jacaAntibibrinoliticos ddavp-jaca
Antibibrinoliticos ddavp-jaca
José Antonio García Erce
 
Manejo perioperatorio del paciente anticoagulado/antiagregado. “Terapia puent...
Manejo perioperatorio del paciente anticoagulado/antiagregado. “Terapia puent...Manejo perioperatorio del paciente anticoagulado/antiagregado. “Terapia puent...
Manejo perioperatorio del paciente anticoagulado/antiagregado. “Terapia puent...
José Antonio García Erce
 
Criterios “restrictivos” de transfusión de concentrados de hematíes. Dra Antelo
Criterios “restrictivos” de transfusión de concentrados de hematíes. Dra AnteloCriterios “restrictivos” de transfusión de concentrados de hematíes. Dra Antelo
Criterios “restrictivos” de transfusión de concentrados de hematíes. Dra Antelo
José Antonio García Erce
 
Castym PBM. Transfusión de Plasma y Plaquetas. Dra Antelo. jaca 2072018
Castym PBM. Transfusión de Plasma y Plaquetas. Dra Antelo. jaca 2072018Castym PBM. Transfusión de Plasma y Plaquetas. Dra Antelo. jaca 2072018
Castym PBM. Transfusión de Plasma y Plaquetas. Dra Antelo. jaca 2072018
José Antonio García Erce
 
Evolution of transfusion in NAVARRA
Evolution of transfusion in NAVARRAEvolution of transfusion in NAVARRA
Evolution of transfusion in NAVARRA
José Antonio García Erce
 
GERM Dr Garcia Erce
GERM Dr Garcia ErceGERM Dr Garcia Erce
GERM Dr Garcia Erce
José Antonio García Erce
 
Novedades en hemoterapia. garcia erce. 2018
Novedades en hemoterapia. garcia erce. 2018Novedades en hemoterapia. garcia erce. 2018
Novedades en hemoterapia. garcia erce. 2018
José Antonio García Erce
 

More from José Antonio García Erce (20)

RICA PBM 2023.pptx
RICA PBM 2023.pptxRICA PBM 2023.pptx
RICA PBM 2023.pptx
 
Hemoterapia Basada en Sentido Común. CEX Jaca 2023.pptx
Hemoterapia Basada en Sentido Común. CEX Jaca 2023.pptxHemoterapia Basada en Sentido Común. CEX Jaca 2023.pptx
Hemoterapia Basada en Sentido Común. CEX Jaca 2023.pptx
 
INTRODUCCIÓN AL PBM CEX 2023.pptx
INTRODUCCIÓN AL  PBM CEX 2023.pptxINTRODUCCIÓN AL  PBM CEX 2023.pptx
INTRODUCCIÓN AL PBM CEX 2023.pptx
 
Prodiggest-anemia-y-ferropenia
Prodiggest-anemia-y-ferropeniaProdiggest-anemia-y-ferropenia
Prodiggest-anemia-y-ferropenia
 
Examen. Curso 2018
Examen. Curso 2018Examen. Curso 2018
Examen. Curso 2018
 
Manejo de la anemia y déficit de hierro en paciente urológico. Dr Oliva
Manejo de la anemia y déficit de hierro en paciente urológico. Dr OlivaManejo de la anemia y déficit de hierro en paciente urológico. Dr Oliva
Manejo de la anemia y déficit de hierro en paciente urológico. Dr Oliva
 
Enfermedades poco frecuentes que predisponen a la trombosis
Enfermedades poco frecuentes que predisponen a la trombosis Enfermedades poco frecuentes que predisponen a la trombosis
Enfermedades poco frecuentes que predisponen a la trombosis
 
Casos Clínicos. Dr Jericó. Jaca 2018
Casos Clínicos. Dr Jericó. Jaca 2018Casos Clínicos. Dr Jericó. Jaca 2018
Casos Clínicos. Dr Jericó. Jaca 2018
 
Patient Blood Management. Prof A Herrera
Patient Blood Management. Prof A Herrera Patient Blood Management. Prof A Herrera
Patient Blood Management. Prof A Herrera
 
Actualización en Hemorragia Masiva. Jaca 2018
Actualización en Hemorragia Masiva. Jaca 2018Actualización en Hemorragia Masiva. Jaca 2018
Actualización en Hemorragia Masiva. Jaca 2018
 
Primer pilar del pbm ( jaca18) Dra Bisbe
Primer pilar del pbm ( jaca18) Dra BisbePrimer pilar del pbm ( jaca18) Dra Bisbe
Primer pilar del pbm ( jaca18) Dra Bisbe
 
Manejo de anemia y ferropenia (prodiggest). Jaca 2018
Manejo de anemia y ferropenia (prodiggest). Jaca 2018Manejo de anemia y ferropenia (prodiggest). Jaca 2018
Manejo de anemia y ferropenia (prodiggest). Jaca 2018
 
“Nuevas Pruebas”: Test de Generación de Trombina, Técnicas viscoelásticas, t...
“Nuevas Pruebas”: Test de Generación de Trombina,  Técnicas viscoelásticas, t...“Nuevas Pruebas”: Test de Generación de Trombina,  Técnicas viscoelásticas, t...
“Nuevas Pruebas”: Test de Generación de Trombina, Técnicas viscoelásticas, t...
 
Antibibrinoliticos ddavp-jaca
Antibibrinoliticos ddavp-jacaAntibibrinoliticos ddavp-jaca
Antibibrinoliticos ddavp-jaca
 
Manejo perioperatorio del paciente anticoagulado/antiagregado. “Terapia puent...
Manejo perioperatorio del paciente anticoagulado/antiagregado. “Terapia puent...Manejo perioperatorio del paciente anticoagulado/antiagregado. “Terapia puent...
Manejo perioperatorio del paciente anticoagulado/antiagregado. “Terapia puent...
 
Criterios “restrictivos” de transfusión de concentrados de hematíes. Dra Antelo
Criterios “restrictivos” de transfusión de concentrados de hematíes. Dra AnteloCriterios “restrictivos” de transfusión de concentrados de hematíes. Dra Antelo
Criterios “restrictivos” de transfusión de concentrados de hematíes. Dra Antelo
 
Castym PBM. Transfusión de Plasma y Plaquetas. Dra Antelo. jaca 2072018
Castym PBM. Transfusión de Plasma y Plaquetas. Dra Antelo. jaca 2072018Castym PBM. Transfusión de Plasma y Plaquetas. Dra Antelo. jaca 2072018
Castym PBM. Transfusión de Plasma y Plaquetas. Dra Antelo. jaca 2072018
 
Evolution of transfusion in NAVARRA
Evolution of transfusion in NAVARRAEvolution of transfusion in NAVARRA
Evolution of transfusion in NAVARRA
 
GERM Dr Garcia Erce
GERM Dr Garcia ErceGERM Dr Garcia Erce
GERM Dr Garcia Erce
 
Novedades en hemoterapia. garcia erce. 2018
Novedades en hemoterapia. garcia erce. 2018Novedades en hemoterapia. garcia erce. 2018
Novedades en hemoterapia. garcia erce. 2018
 

Recently uploaded

June 2024 Oncology Cartoons By Dr Kanhu Charan Patro
June 2024 Oncology Cartoons By Dr Kanhu Charan PatroJune 2024 Oncology Cartoons By Dr Kanhu Charan Patro
June 2024 Oncology Cartoons By Dr Kanhu Charan Patro
Kanhu Charan
 
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptxVestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
MERCURY GROUP.BHMS.MATERIA MEDICA.HOMOEOPATHY
MERCURY GROUP.BHMS.MATERIA MEDICA.HOMOEOPATHYMERCURY GROUP.BHMS.MATERIA MEDICA.HOMOEOPATHY
MERCURY GROUP.BHMS.MATERIA MEDICA.HOMOEOPATHY
DRPREETHIJAMESP
 
CLEAR ALIGNER THERAPY IN ORTHODONTICS .pptx
CLEAR ALIGNER THERAPY IN ORTHODONTICS .pptxCLEAR ALIGNER THERAPY IN ORTHODONTICS .pptx
CLEAR ALIGNER THERAPY IN ORTHODONTICS .pptx
Government Dental College & Hospital Srinagar
 
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptxREGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
LaniyaNasrink
 
Cervical Disc Arthroplasty ORSI 2024.pptx
Cervical Disc Arthroplasty ORSI 2024.pptxCervical Disc Arthroplasty ORSI 2024.pptx
Cervical Disc Arthroplasty ORSI 2024.pptx
LEFLOT Jean-Louis
 
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.GawadHemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
NephroTube - Dr.Gawad
 
The Nervous and Chemical Regulation of Respiration
The Nervous and Chemical Regulation of RespirationThe Nervous and Chemical Regulation of Respiration
The Nervous and Chemical Regulation of Respiration
MedicoseAcademics
 
Travel Clinic Cardiff: Health Advice for International Travelers
Travel Clinic Cardiff: Health Advice for International TravelersTravel Clinic Cardiff: Health Advice for International Travelers
Travel Clinic Cardiff: Health Advice for International Travelers
NX Healthcare
 
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdfCHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
rishi2789
 
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdfCHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
rishi2789
 
NARCOTICS- POLICY AND PROCEDURES FOR ITS USE
NARCOTICS- POLICY AND PROCEDURES FOR ITS USENARCOTICS- POLICY AND PROCEDURES FOR ITS USE
NARCOTICS- POLICY AND PROCEDURES FOR ITS USE
Dr. Ahana Haroon
 
Pharmacology of 5-hydroxytryptamine and Antagonist
Pharmacology of 5-hydroxytryptamine and AntagonistPharmacology of 5-hydroxytryptamine and Antagonist
Pharmacology of 5-hydroxytryptamine and Antagonist
Dr. Nikhilkumar Sakle
 
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotesPromoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
PsychoTech Services
 
Complementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLSComplementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLS
chiranthgowda16
 
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptxEar and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
share - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptxshare - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptx
Tina Purnat
 
DECLARATION OF HELSINKI - History and principles
DECLARATION OF HELSINKI - History and principlesDECLARATION OF HELSINKI - History and principles
DECLARATION OF HELSINKI - History and principles
anaghabharat01
 
Tests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptxTests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptx
taiba qazi
 
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấuK CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
HongBiThi1
 

Recently uploaded (20)

June 2024 Oncology Cartoons By Dr Kanhu Charan Patro
June 2024 Oncology Cartoons By Dr Kanhu Charan PatroJune 2024 Oncology Cartoons By Dr Kanhu Charan Patro
June 2024 Oncology Cartoons By Dr Kanhu Charan Patro
 
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptxVestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
 
MERCURY GROUP.BHMS.MATERIA MEDICA.HOMOEOPATHY
MERCURY GROUP.BHMS.MATERIA MEDICA.HOMOEOPATHYMERCURY GROUP.BHMS.MATERIA MEDICA.HOMOEOPATHY
MERCURY GROUP.BHMS.MATERIA MEDICA.HOMOEOPATHY
 
CLEAR ALIGNER THERAPY IN ORTHODONTICS .pptx
CLEAR ALIGNER THERAPY IN ORTHODONTICS .pptxCLEAR ALIGNER THERAPY IN ORTHODONTICS .pptx
CLEAR ALIGNER THERAPY IN ORTHODONTICS .pptx
 
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptxREGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
 
Cervical Disc Arthroplasty ORSI 2024.pptx
Cervical Disc Arthroplasty ORSI 2024.pptxCervical Disc Arthroplasty ORSI 2024.pptx
Cervical Disc Arthroplasty ORSI 2024.pptx
 
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.GawadHemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
 
The Nervous and Chemical Regulation of Respiration
The Nervous and Chemical Regulation of RespirationThe Nervous and Chemical Regulation of Respiration
The Nervous and Chemical Regulation of Respiration
 
Travel Clinic Cardiff: Health Advice for International Travelers
Travel Clinic Cardiff: Health Advice for International TravelersTravel Clinic Cardiff: Health Advice for International Travelers
Travel Clinic Cardiff: Health Advice for International Travelers
 
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdfCHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
 
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdfCHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
 
NARCOTICS- POLICY AND PROCEDURES FOR ITS USE
NARCOTICS- POLICY AND PROCEDURES FOR ITS USENARCOTICS- POLICY AND PROCEDURES FOR ITS USE
NARCOTICS- POLICY AND PROCEDURES FOR ITS USE
 
Pharmacology of 5-hydroxytryptamine and Antagonist
Pharmacology of 5-hydroxytryptamine and AntagonistPharmacology of 5-hydroxytryptamine and Antagonist
Pharmacology of 5-hydroxytryptamine and Antagonist
 
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotesPromoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
 
Complementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLSComplementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLS
 
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptxEar and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
 
share - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptxshare - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptx
 
DECLARATION OF HELSINKI - History and principles
DECLARATION OF HELSINKI - History and principlesDECLARATION OF HELSINKI - History and principles
DECLARATION OF HELSINKI - History and principles
 
Tests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptxTests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptx
 
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấuK CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
 

VAMPIRISM IN ICU. Anexus. Firenze, Italia. Aprin 2017

  • 1. Vampirism in the Intensive Care Unit: A routine practice? A.M. Ayuso-Alvarez1 , J.A. García Erce2 , S. Gómez-Ramírez3 , A. Sarria4 , M. Muñoz3 , M. Quintana Díaz1,5 1 Intensive Medicine Service, University Hospital La Paz, Madrid; 2 Blood and Tissue Bank of Navarra, Pamplona; 3 Perioperative Transfusion Medicine, University of Málaga, Málaga; 4 National Health School, University of Alcalá (REDISSEC), Alcalá de Henares; 5 Department of Medicine, Autonomous University, Madrid (Spain).
  • 2. NO INTEREST CONFLICT Asesor externo - AMGEN Oncología 2010/2012 - Roche Anemia 2009 - Ditassa-Ferrer 2004 Charlas, estudios investigación y ayudas a congresos -Vifor-Uriach/Ferralinze/AMGEN -Janssen-Cilag/Braun/Celgene/Alexion -Astra-Tech de Aztra Zeneca/Well-Health?/GSK -Sanofi Aventis/Esteve/Novartis/Octapharma -Cobe-Caridian/Roche Oncología/AMGEN Oncologia Miembro del CAT 2002-2005 Miembro del Documento de Sevilla “Alternativas a la Transfusión” Miembro del Documento Latino Americano de la Anemia Miembro de GIEMSA/ Secretario AWGE/Socio SETS/AEHH/NATA Editor Asociado Revista ANEMIA www.revistaanemia.org Miembro Comité Científico NATA y TATM Representante de la SEHH en la ONT Colaborador del Choosing Wisely en Anestesiología Vampirism in the Intensive Care Unit: A routine practice?
  • 3. Vampirism in the Intensive Care Unit: A routine practice?
  • 4. Anaemia, blood loss & transfusion Prof Muñoz Vampirism in the Intensive Care Unit: A routine practice?
  • 6. NEJM 1986 Vampirism in the Intensive Care Unit: A routine practice?
  • 7. JAMA 2002; 288:1499-1507 Vampirism in the Intensive Care Unit: A routine practice?
  • 8. Vampirism in the Intensive Care Unit: A routine practice?
  • 9. http://www.choosingwisely.org/doctor-patient-lists/ Five Recommendations from the Italian Federation of Associations of Hospital Internal Medicine (FADOI) - 1st List (2014) http://www.choosingwiselyitaly.org/PDF/ENGracc/Scheda%20FADOI%20(1)%20english.pdf 4. Don’t repeat chemistry testing in the face of clinical and laboratory stability 2012 Vampirism in the Intensive Care Unit: A routine practice?
  • 10. 2014 Vampirism in the Intensive Care Unit: A routine practice?
  • 11. Objectives Vampirism in the Intensive Care Unit: A routine practice? To evaluate the prevalence and factors associated with of Hospital Acquired Anaemia in patients admitted to Intensive Care Units (ICU).
  • 12. Methods. Prospective, cross-sectional observational study performed at 5 Spanish hospitals during a 4-month period. •Data were collected in successive week-days for 7 weeks. •All patients with ICU <28 days and >24 hours on the day of assessment were included. •Variables: – Clinical and demographic data, – Phlebotomies (“drawn”) (number and volume), – Hb change from admission to discharge (DHb), and – Red blood cell transfusion (RBCT) requirements were collected. •Data are mean and SD or 95%CI, or number (percentage). •Student’s t test, Pearson’s χ2 test and lineal regression were performed. Vampirism in the Intensive Care Unit: A routine practice?
  • 13. Results. Overall, 561 patients (66% male) were included. Mean age was 58 years; Mean SOFA at admission 5.7± 0.1 APACHE II score at 24 hours 18.3 ± 0.3. Mean length of ICU stay was 21 days (95%CI: 19-22 days); ICU mortality rate 12%. Most frequent reasons for ICU admission were: neurologic (24%), respiratory (12%), infectious (12%), or cardiovascular diseases (10%). Vampirism in the Intensive Care Unit: A routine practice?
  • 14. Results. No anemia Mild anemia Moderate anemia Severe anaemia All patients p Patients, n 196 213 118 34 561 --- Admission Hb (g/dL) 14.2 11.2 9.3 6.9 11.5 <0.001 Phlebotomy (mL/day) 31 33 30 32 31 0.468 Surgery, n (%) 66 (34) 88 (41) 47 (40) 9 (27) 244 (38) 0.212 Transfusion, n (%) 42 (21) 85 (40) 69 (58) 30 (88) 260 (40) <0.001 RBCT (units/patient) 1.6 1.6 3.0 5.2 2.1 <0.001 ICU stay (days) 21 21 20 22 21 0.916 Discharge Hb (g/dL) 10.5 9.3 8.1 9.0 9.4 <0.001 D Hb (g/dL) -3.0 -1.5 0.1 2.1 -1.5 <0.001 Vampirism in the Intensive Care Unit: A routine practice?
  • 15. Results: Anaemia at Admission p<0.001 Vampirism in the Intensive Care Unit: A routine practice?
  • 16. Results: Anaemia evolution Vampirism in the Intensive Care Unit: A routine practice?
  • 17. Results: Relationship Hb discharge and stay at ICU p<0.001 Vampirism in the Intensive Care Unit: A routine practice?
  • 18. Results. Total extracted vol Admission-Discharge Hb Difference Hb ICU discharge RCC Transfused (n) Vampirism in the Intensive Care Unit: A routine practice? PEARSON´S BILATERAL CORRELATION
  • 19. Results. Adjusting for Hb at admission, a linear relationship between the extracted volume / day and the Hb at the discharge (R2 = 0.25, p <0.001) was observed and on the day of the cut (R2 = 0.43, p <0.001). Discharged Hb level Admission-Discharge Hb difference R p R p ICU admission Hb 0,33 <0,001 -0,67 <0,001 Total extracted mL -0,01 0,007 -0,01 0,007 RCC Transfused (n) -0,022 0,160 -0,022 0,160 With no significant relationship to the number of transfused concentrates. Vampirism in the Intensive Care Unit: A routine practice? PEARSON´S MULTILATERAL CORRELATION
  • 20.
  • 21. Conclusions. A significant number of phlebotomies are performed among ICU patients, which associated with the development/maintenance of "acquired anemia." Although 40% require RBCT, it seems to be effective at controlling Hb level only in those with severe anemia at ICU admission. Vampirism in the Intensive Care Unit: A routine practice? Frietz 2014
  • 22. Vampirism in the Intensive Care Unit: A routine practice? EPIGRAPH “All great work is the fruit of patience and perseverance, combined with tenacious concentration on a subject over a period of months or years” Dr Santiago Ramón y Cajal Navarra-Aragón Medicine´s Nobel Prize Please, DONATe and tranfuse WISELY!

Editor's Notes

  1. 10,3 mL/draw; 41,1 mL/24 h; correlation between organ dysfunction between number of blood draws total volumen drawn